SynthesisJournal of neural transmission (Vienna, Austria : 1996)2026
Resting-state EEG changes associated with cognitive decline in Parkinson's disease: a systematic review.
Synthesis in Journal of neural transmission (Vienna, Austria : 1996), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- An Interpretable Framework for Identifying EEG Spectral Biomarkers of Pathological Brain Aging.Diagnostics (Basel, Switzerland) · 2026Article
- [Advances in research on neuroelectrophysiological characteristics of post-stroke cognitive impairment based on quantitative electroencephalography and acupuncture interventions].Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cognitive decline is a common and disabling feature of Parkinson's disease (PD), frequently progressing from mild cognitive impairment to Parkinson's disease dementia. Due to substantial heterogeneity in PD phenotypes, current research is increasingly focused on identifying robust biomarkers to predict which individuals are at higher risk of cognitive deterioration relative to those likely to exhibit cognitive stability. Electroencephalography (EEG), a non-invasive and cost-efficient method for measuring neural activity, has shown potential in detecting early electrophysiological alterations associated with cognitive decline in PD. This review aims to summarise recent findings on the utility of resting-state quantitative EEG measures as candidate biomarkers for cognitive trajectory in PD. Relevant studies from over the last 10 years were retrieved through PubMed and Scopus, resulting in the inclusion and evaluation of 67 articles. Distinct EEG features, identified using various analytic approaches, were found to discriminate PD patients across different cognitive stages, as well as from those cognitively unimpaired and healthy controls. We suggest that EEG surrogate markers may be a valuable tool in conjunction with clinical and genetic variables to help early detection and monitoring, as well as development of personalised interventions for cognitive impairment in PD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.